SATURDAY, AUGUST 15, 2015Session I7:00 am Registration, Exhibits and Continental Breakfast7:45 am Welcome – Dr. Dhanunjaya Lakkireddy8:00 am Advanced Heart Failure Management – Role of Dynamic Intracardiac Pressure

Monitors and Ventricular Assist Devices – Dr. Thomas Deering8:15 am Improving the E�cacy of CRT Implant – Quadripolar LV Leads, Atrioventricular

Timing Intervals and Other Methods of Optimization – Dr. Eduardo Saad8:30 am Ablation as Salvation – Improving CRT Response by Targeting Cardiac Arrhythmias

-- Dr. Luigi Di Biase8:45 am DFT Testing – Is it still Relevant in 2015? -- Dr. Mark KrollSession II9:00 am KU Pioneers in Cardiovascular Electrophysiology Award –Keynote Address

– Dr. Jeremy Ruskin9:30 am Management of Lead Failures – Why, What and How? – Dr. Loren Berenbom9:45 am Leadless Pacemakers –What Have We Learned in the Past Two Years

– Dr. Dhanunjaya Lakkireddy10:00 am BreakSession III10:15 am Heart Rhythm Monitors – State of the State in Injectable, Wearable and

Adhesesable Devices – Dr. Rhea Pimentel10:30 am Subcutaneous ICDs – What They Can and Can’t Do? – TBA10:45 am Can Capsulectomy During Generator Changes Decrease the Risk of Pocket Infections?

– Dr. Rahuveer Dendi 11:00 am Biological Pacemakers, Cardiac Regeneration and More – Stem Cell Treatment in

2015 – TBA11:15 am Panel DiscussionSession IV11:30 am Debate: MRIs Can be Done Only in Patients with Compatible Devices

– Dr. Tandri Harikrishna and TBA12:15 pm Generator Replacements in Primary Prevention ICD Indication – Time to Re-apprise

the Continued Need for De�brillator Therapy – Dr. Martin Emert12:30 pm LunchSession V1:00 pm LAA Exclusion – Watchman, LARIAT, and Atriclip – When and How?

– Dr. Moussa Mansour1:15 pm Novel Oral Anticoagulants – Trials, Triumphs and Tribulations – Dr. Daniel Singer1:30 pm Periprocedural Management of Anticoagulation and Antiplatelet Agents in EP

Practice – Dr. Douglas Packer1:45 pm Debate: Left Atrial Appendage Exclusion Should be O�ered Only to Patients with

are High Risk for Bleeding and Stroke – Dr. Vivek Reddy and Dr. David Wilber2:15 pm Panel DiscussionSession VI 2:30 pm E�ective Utilization of Cardiac CT, MRI, TEE and ICE for EP Procedures – Tips from the

Expert – Dr. Kalyanam Shivkumar2:45 pm Atrial Substrate Rotors in Atrial Fibrillation – Myth or Truth? Dr. Eric Buch3:00 pm What has Changed in SVT Ablation since the 1990s and How to Manage an Unusual

SVT? – Dr. Sonny Jackman

3:15 pm LAA Exclusion – The Impact on Stroke Risk, Atrial Arrhythmias, Atrial Reservoir and Neuroendocrine Function – Dr. Dhanunjaya Lakkireddy

3:30 pm BreakSession VII3:45 pm Role of Anesthesiologist in the EP World – Sedation, Ventilation, Nerve Blocks and

More – Dr. Jason Mensch4:00 pm Managing Anticoagulation or Antiplatelet Agents Around Cerebrovascular Accident –

A Neurologist’s Perspective – Dr. Daniel Singer4:15 pm Cardiac Dysautonomia – Teasing out the Di�erences and Specializing in Therapies

– Dr. Thomas Deering4:30 pm Genetic Testing for Inherited Arrhythmias Syndromes – Better Clinical Care or Intrusion

of Privacy? – Dr. George Van Hare4:45 pm My Most Interesting Cases – Dr. Madhu Reddy and Dr. Sanjaya Gupta5:30 pm Adjourn

SUNDAY, AUGUST 16, 2015Session VIII7:15 am Dr. Manohar Sai Gowda Young Investigator Cardiovascular Research AwardSession IX8:15 am Debate: Hemodynamic Support Should be used for Every Scar VT Ablation

– Dr. Vivek Reddy and Dr. Kalyanam Shivkumar9:00 am VT Ablation in 2015 Fact Check – Focused Targeted Treatment or Widespread substrate

Modi�cation? – Dr. Venkat Tholakanahalli 9:15 am Maximizing Success Rates of Ventricular Arrhythmias from Di�cult Anatomic Sites –

Notes from the Master Blaster – Dr. Douglas Packer9:30 am Epicardial Ablation – Access, Mapping and Ablation – Improving Safety and E�cacy

– Dr. Young Hoon Kim9:45 am Autonomic Modulation for Cardiac Arrhythmia Treatment – Yoga to Stellate

Gangionectomy – Dr. Sonny Jackman10:00 am BreakSession X10:15 am Understanding the Atrial Substrate – Scar, Triggers, Gangia and Rotors

– Dr. Luigi Di Biase10:30 am Contact Force in Radiofrequency Ablation – True Gains or Merely Added Procedural

Costs? -- Dr. Moussa Mansour10:45 am What is the Most E�ective and Safest Way of Achieving Durable Pulmonary Vein

Isolation? – Dr. Tandri Harikrishna11:00 am Role of AV Node Ablation for AF Treatment in 2015 – When and Who?

– Dr. Eduardo SaadSession XI11:15 am How to Raise the Ceiling on the Treatment Success in Patient with non-Paroxysmal AF?

– Dr. David Wilber11:30 am Primary Prevention of AF – Can it become a Reality or an Eternal Dream?

– Dr. Jeremy Ruskin11:45 am Pleasures of Life and AF: Co�ee, Alcohol, Exercise and More – Dr. Madhu Reddy12:00 pm Vision 2020: Updates from Industry Partners – Dr. Kenneth Stein12:30 pm Closing Remarks

KANSAS CITY HEART RHYTHM SYMPOSIUM 2015August 15-16, 2015 | Sheraton Kansas City Hotel at Crown Center

Kansas City, Missouri

C O U R S E P R O G R A MContinuing Education Credit is available. Register at www.kchrs.com

KANSAS CITY HEART RHYTHMSYMPOSIUM 2015August 15-16, 2015

Sheraton Kansas City Hotel at Crown Center

Continuing Education Credit is availableRegister at www.kchrs.com

KU PIONEERS IN ELECTROPHYSIOLOGY AWARDRECIPIENT & KEYNOTE SPEAKER: Jeremy N. Ruskin, MD

University of KansasContinuing Education1515 Saint Andrews DriveLawrence, KS 66047-1619

Sponsored by:The Richard & Annette Bloch Heart Rhythm Center,

Mid-America Cardiology, The University of Kansas Hospital, and University of Kansas Medical Center Continuing Education

Dr. Jeremy Ruskin is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Ruskin received his undergraduate degree summa cum laude from Tufts University in 1967 and his medical degree cum laude from Harvard Medical School in 1971. He completed a residency in Internal Medicine at Beth Israel Hospital in Boston from 1971-1973 after which received his training in clinical cardiac electrophysiology at the USPHS Hospital in Staten Island, New York under the mentorship of Dr. Anthony Damato from 1973-1975. He then completed a clinic and research fellowship in Cardiovascular Disease at the Massachusetts General Hospital from 1975-1978. In 1978, Dr. Ruskin founded the MGH Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory, the �rst subspecialty service dedicated to the care of patients with cardiac arrhythmias in New England and one of the �rst in the United States. Since its inception, the MGH Cardiac Arrhythmia Service has been a leader in cutting edge clinical care, the training of future leaders in clinical cardiac electrophysiology, and research on the mechanisms of and innovative therapies for the treatment of cardiac arrhythmias. As founder and director of the MGH Fellowship training program in clinical cardiac electrophysiology in 1978, Dr. Ruskin has been responsible for the training and mentorship for more than 110 clinical and research fellows in the subspecialty of cardiac arrhythmias over the past 37 years, many of whom are in leadership positions at academic centers throughout the world. Dr. Ruskin serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee for 5 years and as a consultant to the National Center for Health Services Research and Healthy Care Technology Assessment. For the past twenty �ve years, he has worked extensively on the scienti�c and regulatory aspects of medical device and drug development as wells as cardiovascular drug safety. In 1995, Dr. Ruskin founded the Annual International Atrial Fibrillation Symposium which he has directed since its inception and is the largest and longest running free-standing academic meeting on atrial �brillation worldwide, now entering its twenty �rst year. Dr. Ruskin’s major research interests include the mechanisms and management of atrial �brillation, new antiarrhythmic drugs and innovative technologies for catheter ablation of atrial �brillation, the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death, risk strati�cation for sudden death, the proarrhythmic e�ects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development. He is an author of more than 400 original scienti�c publications, chapters, reviews, guidelines and monographs. Dr. Ruskin also maintains an active regional, national and international referral practice in the �eld of cardiac arrhythmias and electrophysiology and is recognized annually in Best Doctors in America and Best Doctors in Boston. Dr. Ruskin is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.